We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
He added: "Alongside the OTCQB trading, Apollon is also exploring an up-listing to another larger more liquid exchange. Whilst we cannot provide any further detail at this stage, we will continue to explore these opportunities to drive shareholder value."
Apollon said it believes a move to a more well-established exchange will provide easier trading access for institutional investors and improve liquidity for all shareholders.
https://www.proactiveinvestors.co.uk/companies/news/973611/apollon-formularies-set-for-us-listing-on-otcqb-973611.html
mmmm seems like really positive news. not buying anymore but still hold plenty to make a few quid if one day this becomes great. gla
Released this morning
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international pharmaceutical company trading on the Aquis Stock Exchange and focused on the treatment of various cancer conditions using its proprietary medical cannabis formulations, is pleased to announce it is advancing an application to join the OTCQB Market ("OTCQB") in the United States. Apollon's Ordinary Shares will continue to trade on the Aquis Stock Exchange under the symbol APOL.
The Company decided to undertake this application for a second trading platform for its shares at the request of several US based investors and believes that cross trading on the OTCQB will provide enhanced investor benefits, including easier access for potential investors in North America, increased trading hours and improved trading liquidity.
Apollon is also pleased to announce that it is exploring other possible up-listing options on local and international exchanges to increase investor access. The Company will maintain its existing AQSE listing, in addition to any additional up-listing it may undertake.
The Company believes that, due to the growth it has seen both in terms of the build out of its facilities and the increase in patient enquiries, moving to a more well-established exchange will provide easier trading access for institutional investors and improve liquidity for all shareholders.
The Company will provide further detail in due course.
like most shares especially under the radar this wont move until revenue and profit is easy to see
Apollon is pleased to add that the Company is experiencing demand from international patients who wish to be treated in Jamaica and will be admitting its second UK patient in mid-February 2022.
https://finance.yahoo.com/news/apollon-formularies-plc-announces-grand-070000179.html
Apollon Formularies
@apollon_uk
·
14m
Apollon to significantly increase its inventory in preparation for global export
Increased capacity provides readily available inventory for potential pharmaceutical partners to perform independent clinical trial validation
Apollon Formularies
@apollon_uk
·
3h
"These #APOL formulation test results on prostate cancer and the plan to immediately begin treatments in Jamaica are extremely exciting developments, in part, because traditional chemotherapy, radiation, and surgery cancer treatment protocols are expensive"
https://twitter.com/apollon_uk
Jan 27, 2022
Apollon Formularies names Dr Herbert Fritsche as director
https://www.apollon.org.uk/news-and-media/
The farmer group will want to get growing asap IMHO.................
Hi Kenny, once they get to making 32L per day, pretty sure there will be revenue coming from somewhere.
On a 5 day week.............LOL
1-liter Plain Jane Bulk CBD Distillate (Full Spectrum), 82% CBD: $3,960.00 X 32 LTRS per day =$32947200.00 per year.
Bulk CBD Oil Pricing
If you are interested in ordering bulk CBD distillate (or other wholesale hemp products) from Plain Jane, you can email their wholesale specialists. List prices are not negotiable.
1-liter Plain Jane Bulk CBD Distillate (Full Spectrum), 82% CBD: $3,960.00
1-liter Plain Jane Bulk CBD Distillate (Isolate), 85% CBD: $3,500.00
1-liter Plain Jane Bulk CBD Crude (Full Spectrum, Unrefined), 57% CBD: $1,320.00
https://blog.plainjane.com/how-much-is-a-kg-of-cbd-oil/
https://loudcloudhealth.com/resources/cbd-statistics-infographic/
26% of people believe that CBD and marijuana are the same thing.
The number of licensed hemp growers in the US increased by 27%.
A cannabis worker earns more than an average American.
9 million people started using CBD for the first time due to the pandemic.
Americans spend an average of $20–$80 per month on CBD.
CBD sales in the US are predicted to reach about $1.8 billion by 2022.
The number of licensed hemp growers in the US increased by 27%.
68% of Americans are in favor of legalizing cannabis.
9 in 10 pet owners would recommend CBD as a way of pet treatment.
CBD can help treat heroin addiction.
Director of Enforcement and Monitoring at the Cannabis Licensing Authority (CLA), Faith Graham, speaking at a recent Jamaica Information Service (JIS) Think Tank, stated that “by insisting on a standard for our licence holders and those interested in becoming a part of our local market, we are showing that we operate at an international level as we apply best practices for the global industry”. Ms. Graham continued, “the CLA operates a closed loop system, characterized by a tripartite agreement that is fundamental to the industry maintaining its integrity. The tripartite agreement ensures that the ganja (cannabis) that is cultivated is sold to another licensee.”¹
Should please the farmer group...............IMHO
Apollon Formularies
@apollon_uk
·
20m
(2/2) The successful expansion of the production facility also provides opportunities for new revenue streams, which can facilitate more research. The expansion also bolsters inventory for our intended exports markets once terms have been agreed
https://twitter.com/apollon_uk/status/1487032917058625540
(1/2) Apollon's new state-of-the-art distiller has increased production significantly, with processing capacity rising to 20L per day of analytically validated #medicalcannabis oil. #APOL plans to raise this to 32L daily which would mean a 50x increase compared to prior expansion